PSC
HSTO

Piper Sandler & Co’s Histogen Inc. Common Stock HSTO Stock Holding History

Piper Sandler & Co’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-31
Closed -$38K – 171
2014
Q3 		$38K Buy
31
+26
+520% +$37.4K 0.02% 112
2014
Q2 		$9K Buy
+5
New +$6.68K 0.01% 112

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Piper Sandler & Co's HSTO Position: Q4 2014 in Review

Piper Sandler & Co sold out of Histogen Inc. Common Stock (HSTO) in Q4 2014, closing a stake of 31 shares — an estimated $38K sold.

Piper Sandler & Co first reported a position in HSTO in Q2 2014 and held it in 2 quarters. The position peaked at $38K in Q3 2014. 36 funds tracked by Wall St. Rank hold HSTO as of Q4 2014.

  • Piper Sandler & Co reported no remaining Histogen Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 31 Histogen Inc. Common Stock shares in Q4 2014, an estimated $38K.
  • Piper Sandler & Co first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • Piper Sandler & Co's Histogen Inc. Common Stock position peaked at $38K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2014.

Based on Piper Sandler & Co's 13F filing for Q4 2014, filed 17 Feb 2015.